ExploRNA Therapeutics today announced that AS ONE Corporation has been appointed as one of its distributors in Japan.
Under the agreement, AS ONE will offer ExploRNA’s cap analog products, including ExploCap, AvantCap AG, AvantCap Q1 and AvantCap Q2, to customers in Japan.
“We are pleased to begin working with AS ONE Corporation in Japan,” said Professor Jacek Jemielity, CEO of ExploRNA Therapeutics. “We look forward to introducing our products to researchers and customers in the Japanese market through ASONE’s distribution network.”
AS ONE and ExploRNA will work together to increase awareness and availability of ExploRNA products in Japan.
